| 45 | Humans (MeSH) |
| 20 | Parkinson Disease (rehabilitation) |
| 19 | Male (MeSH) |
| 19 | Female (MeSH) |
| 18 | Parkinson Disease (therapy) |
| 16 | Dance Therapy (MeSH) |
| 15 | Aged (MeSH) |
| 14 | Parkinson's disease |
| 13 | Parkinson Disease (physiopathology) |
| 10 | Gait (MeSH) |
| 10 | Dancing (MeSH) |
| 9 | Treatment Outcome (MeSH) |
| 9 | Middle Aged (MeSH) |
| 9 | Dance Therapy (methods) |
| 8 | Postural Balance (physiology) |
| 6 | dystonia |
| 6 | Quality of Life (MeSH) |
| 6 | Pilot Projects (MeSH) |
| 6 | Physical Therapy Modalities (MeSH) |
| 6 | Parkinson Disease (psychology) |
| 6 | Music Therapy (MeSH) |
| 6 | Exercise Therapy (methods) |
| 5 | parkinsonism |
| 5 | Walking (MeSH) |
| 5 | Postural Balance (MeSH) |
| 5 | Parkinson disease |
| 5 | Gait (physiology) |
| 4 | Severity of Illness Index (MeSH) |
| 4 | Randomized Controlled Trials as Topic (MeSH) |
| 4 | Aged, 80 and over (MeSH) |
| 4 | Adult (MeSH) |
| 4 | Activities of Daily Living (MeSH) |
| 3 | deep brain stimulation |
| 3 | Time Factors (MeSH) |
| 3 | Prospective Studies (MeSH) |
| 3 | Music (MeSH) |
| 3 | Motor Activity (physiology) |
| 3 | Disease Progression (MeSH) |
| 3 | Brain (physiology) |
| 3 | Antiparkinson Agents (therapeutic use) |
| 2 | tremor |
| 2 | transcranial magnetic stimulation |
| 2 | rehabilitation |
| 2 | myoclonus |
| 2 | leucine‐rich repeat kinase 2 |
| 2 | gait disorder |
| 2 | chorea |
| 2 | aging |
| 2 | Watchful Waiting (MeSH) |
| 2 | Walking (physiology) |
| 2 | Tourette syndrome |
| 2 | Task Performance and Analysis (MeSH) |
| 2 | Single-Blind Method (MeSH) |
| 2 | Residence Characteristics (MeSH) |
| 2 | Psychomotor Performance (MeSH) |
| 2 | Parkinson’s disease |
| 2 | Parkinson Disease (epidemiology) |
| 2 | Parkinson Disease (drug therapy) |
| 2 | Nervous system diseases |
| 2 | Movement (physiology) |
| 2 | Magnetic Resonance Imaging (MeSH) |
| 2 | Huntington's disease |
| 2 | Human |
| 2 | Gait Disorders, Neurologic (rehabilitation) |
| 2 | Follow-Up Studies (MeSH) |
| 2 | Exercise (MeSH) |
| 2 | Event evoked potential |
| 2 | Electroencephalography (MeSH) |
| 2 | Disability Evaluation (MeSH) |
| 2 | Dancing (physiology) |
| 2 | Antiparkinson Agents (adverse effects) |
| 2 | Analysis of Variance (MeSH) |
| 1 | working ingredients |
| 1 | white‐matter changes |
| 1 | vision |
| 1 | treatment |
| 1 | transcription factor |
| 1 | transcallosal |
| 1 | tractography |
| 1 | tourettism |
| 1 | total sway path length |
| 1 | torticollis |
| 1 | topiramate |
| 1 | tongue movement |
| 1 | tics |
| 1 | therapy research |
| 1 | thalamic lesion |
| 1 | tardive dyskinesia |
| 1 | systems |
| 1 | sway area |
| 1 | swallowing; Parkinson's disease |
| 1 | susceptibility |
| 1 | superior cerebellar peduncle |
| 1 | subthreshold depression |
| 1 | substantia nigra |
| 1 | striatal hypometabolism |
| 1 | stiff‐person syndrome |
| 1 | stiff‐limb syndrome |
| 1 | static balance |
| 1 | spinocerebellar ataxia |
| 1 | spinocerebellar ataxia type 2 |
| 1 | shamanic trance |
| 1 | sensory tricks |
| 1 | self‐assessment |
| 1 | schizophrenia |
| 1 | satiety |
| 1 | rimonabant |
| 1 | rigidity |
| 1 | rhythmic auditory stimulation |
| 1 | rejection behaviour |
| 1 | reflex |
| 1 | reality orientation |
| 1 | rapid‐onset dystonia–parkinsonism |
| 1 | quality of life |
| 1 | qualitative research |
| 1 | pyridoxal 5‐phosphate |
| 1 | punding |
| 1 | psychosocial interventions |
| 1 | psychopathology |
| 1 | protein oxidation |
| 1 | proteasome |
| 1 | propriospinal myoclonus |
| 1 | progressive supranuclear palsy |
| 1 | procedural memory stimulation |
| 1 | primary |
| 1 | pregnancy |
| 1 | postural instability |
| 1 | postural control |
| 1 | pluralistic point of view |
| 1 | plasticity |
| 1 | physiological tremor |
| 1 | physical activity |
| 1 | phenotype‐ genotype correlation |
| 1 | pharmacological tolerance |
| 1 | persistent developmental stuttering |
| 1 | pediatric |
| 1 | pathophysiology |
| 1 | participation |
| 1 | partial coherence |
| 1 | parietal avoiding syndrome |
| 1 | pallidotomy |
| 1 | paired‐like homodomain transcription factor 3 |
| 1 | oxidative stress |
| 1 | obesity |
| 1 | nursing |
| 1 | neurophysiology |
| 1 | neuropharmacology |
| 1 | neuroleptics |
| 1 | neuroimagery |
| 1 | neurodegeneration with brain iron accumulation; pantothenate kinase–associated neurodegeneration; deferiprone; magnetic resonance imaging; iron |
| 1 | narcolepsy |
| 1 | music |
| 1 | music therapy |
| 1 | multidisciplinary approach |
| 1 | motor training |
| 1 | motor tic disorder |
| 1 | motor symptoms |
| 1 | motor neuron disease |
| 1 | motor fluctuations |
| 1 | motor cortex |
| 1 | motor complications |
| 1 | monamine oxidase inhibitors |
| 1 | middle‐range theory |
| 1 | melanocyte‐inhibiting factor (MIF) |
| 1 | marmoset |
| 1 | long‐term efficacy |
| 1 | liquids |
| 1 | levodopa |
| 1 | leukaemia |
| 1 | kainate receptor |
| 1 | ipsilateral silent period |
| 1 | interhemispheric |
| 1 | insulin resistance |
| 1 | impulse control disorder |
| 1 | hypoxia |
| 1 | hypocretin |
| 1 | hypnosis |
| 1 | human body balance |
| 1 | high‐resolution melting |
| 1 | hereditary spastic paraplegia |
| 1 | hemiparkinsonism |
| 1 | hemichorea |
| 1 | hemiballism |
| 1 | heart rate variability |
| 1 | health outcomes |
| 1 | gèste antagonistique |
| 1 | gut hormones |
| 1 | globus pallidus |
| 1 | genetics |
| 1 | gastric myoelectrical activity |
| 1 | gambling |
| 1 | gait |
| 1 | gait variability |
| 1 | freezing |
| 1 | freezing of gait |
| 1 | fiber tracking |
| 1 | exercise |
| 1 | essential tremor |
| 1 | environment |
| 1 | energy homeostasis |
| 1 | energy deficiency |
| 1 | electronic patient diary |
| 1 | electromyography |
| 1 | electromyogram |
| 1 | electroencephalogram |
| 1 | electrodermal resistance |
| 1 | dyskinesias |
| 1 | dyskinesia |
| 1 | dynamic balance |
| 1 | drug‐induced psychosis |
| 1 | dopamine |
| 1 | dopamine agonists |
| 1 | disabled children |
| 1 | diffusion tensor magnetic resonance imaging |
| 1 | diffusion tensor imaging |
| 1 | dementia |
| 1 | creative drive |
| 1 | counselling |
| 1 | corticomuscular coherence |
| 1 | cortex |
| 1 | contrast sensitivity |
| 1 | compulsive disorders |
| 1 | compulsions |
| 1 | cognitive dysfunction |
| 1 | clozapine |
| 1 | clinical phenomenology |
| 1 | clinical heterogeneity |
| 1 | chorea‐acanthocytosis |
| 1 | cervical dystonia |
| 1 | cerebral palsy |
| 1 | cerebellar atrophy |
| 1 | cerebellar ataxia |
| 1 | center of foot pressure |
| 1 | cell death |
| 1 | catechol‐O‐methyltransferase inhibitors |
| 1 | cataplexy |
| 1 | cannabinoid |
| 1 | calpain |
| 1 | calcium |
| 1 | brain |
| 1 | bradykinesia |
| 1 | bortezomib |
| 1 | body balance tests |
| 1 | biosphere |
| 1 | balance |
| 1 | asymmetric |
| 1 | artistic‐like production |
| 1 | articulography |
| 1 | appetite |
| 1 | apomorphine infusion |
| 1 | apomorphine boluses |
| 1 | anticipation |
| 1 | anticholinergics |
| 1 | amphetamine |
| 1 | amantadine |
| 1 | alpha-Synuclein (genetics) |
| 1 | abdominal muscles |
| 1 | YGTSS = Yale Global Tic Severity Scale |
| 1 | Water |
| 1 | Verbal comprehension |
| 1 | Upper Extremity (physiopathology) |
| 1 | United States (MeSH) |
| 1 | Ubiquitin-Protein Ligases (genetics) |
| 1 | Tremor (MeSH) |
| 1 | Transcranial Magnetic Stimulation (MeSH) |
| 1 | Transcranial Direct Current Stimulation (MeSH) |
| 1 | Theta Rhythm (MeSH) |
| 1 | The Notebooks of Malte Laurids Brigge |
| 1 | Tai Ji (methods) |
| 1 | TS = Tourette syndrome |
| 1 | THAP1 |
| 1 | TD = tardive dyskinesia |
| 1 | TCA = tricyclic antidepressant |
| 1 | Sulphated polysaccharides |
| 1 | Speech Therapy (methods) |
| 1 | Space Perception (physiology) |
| 1 | Social Participation (MeSH) |
| 1 | Sleep disorder |
| 1 | Sentence |
| 1 | Sensation (physiology) |
| 1 | Self-Help Groups (MeSH) |
| 1 | Seizures (physiopathology) |
| 1 | Schizophrenia (therapy) |
| 1 | SSRI = selective serotonin reuptake inhibitor |
| 1 | SPG4 |
| 1 | SMA |
| 1 | SIB = self-injurious behaviour |
| 1 | SCA2 |
| 1 | Risk factor |
| 1 | Review |
| 1 | Relaxation Therapy (MeSH) |
| 1 | Reaction time |
| 1 | Reaction Time (physiology) |
| 1 | Rapid eye movement sleep |
| 1 | Rainer Maria Rilke |
| 1 | R1441C |
| 1 | Questionnaires (MeSH) |
| 1 | Quality of Life (psychology) |
| 1 | Psychotherapy, Group (methods) |
| 1 | Psychotherapy (MeSH) |
| 1 | Psychogenic movement disorder |
| 1 | Psychiatric Status Rating Scales (MeSH) |
| 1 | Protein-Serine-Threonine Kinases (genetics) |
| 1 | Protein Kinases (genetics) |
| 1 | Prosody |
| 1 | Practice Guidelines as Topic (MeSH) |
| 1 | Positron-Emission Tomography (MeSH) |
| 1 | Pliability (physiology) |
| 1 | Physical exercise |
| 1 | Physical Therapy Modalities (methods) |
| 1 | Periodicity (MeSH) |
| 1 | Perception (physiology) |
| 1 | Perception (MeSH) |
| 1 | Peak performance |
| 1 | Patient Satisfaction (MeSH) |
| 1 | Patient Education as Topic (MeSH) |
| 1 | Patient Dropouts (MeSH) |
| 1 | Parkinson Disease, Secondary (diagnosis) |
| 1 | Parkinson Disease, Secondary (chemically induced) |
| 1 | Parkinson Disease (prevention & control) |
| 1 | Parkinson Disease (genetics) |
| 1 | Parkinson Disease (diagnosis) |
| 1 | PARK8 |
| 1 | PANDAS = paediatric autoimmune neuropsychiatric disorders associated with group A β-haemolytic streptococcal infections |
| 1 | Outpatient Clinics, Hospital (MeSH) |
| 1 | Oncogene Proteins (genetics) |
| 1 | Occupational Therapy (methods) |
| 1 | OCS = obsessive–compulsive symptoms |
| 1 | OCD = obsessive–compulsive disorder |
| 1 | OCB = obsessive–compulsive behaviour |
| 1 | Norgestrel (adverse effects) |
| 1 | Neuropsychological Tests (MeSH) |
| 1 | Neuroprotective Agents (MeSH) |
| 1 | Neurodegenerative Diseases (psychology) |
| 1 | Neurodegenerative Diseases (physiopathology) |
| 1 | Neuroacanthocytosis |
| 1 | Nervous System Physiological Phenomena (MeSH) |
| 1 | Nervous System Diseases (psychology) |
| 1 | Nervous System Diseases (physiopathology) |
| 1 | NOSI = non-obscene complex socially inappropriate behaviours |
| 1 | NMS = neuroleptic malignant syndrome |
| 1 | Music Therapy (methods) |
| 1 | Music (psychology) |
| 1 | Muscles (physiology) |
| 1 | Muscle, Skeletal (physiology) |
| 1 | Muscle Strength (physiology) |
| 1 | Muscle Rigidity (MeSH) |
| 1 | Movement Disorders (therapy) |
| 1 | Movement (MeSH) |
| 1 | Motor Skills (physiology) |
| 1 | Motor Skills (MeSH) |
| 1 | Motor Cortex (physiopathology) |
| 1 | Motor Cortex (physiology) |
| 1 | Mitochondrial swelling |
| 1 | Mitochondrial enzymes |
| 1 | Metaanalysis |
| 1 | Mental Processes (physiology) |
| 1 | Mental Processes (MeSH) |
| 1 | Medicine |
| 1 | Martial Arts (MeSH) |
| 1 | MDD = major depressive disorder |
| 1 | L‐dopa plasmatic levels |
| 1 | Locomotion (MeSH) |
| 1 | Lewy bodies |
| 1 | Levodopa (adverse effects) |
| 1 | Language (MeSH) |
| 1 | KCNA1 |
| 1 | Ireland (MeSH) |
| 1 | Intracellular Signaling Peptides and Proteins (genetics) |
| 1 | Image Processing, Computer-Assisted (MeSH) |
| 1 | Huntington disease |
| 1 | Hemiplegia (therapy) |
| 1 | Hemiplegia (physiopathology) |
| 1 | Heart Rate (MeSH) |
| 1 | Hand (physiology) |
| 1 | Genetics |
| 1 | Genetic Therapy (MeSH) |
| 1 | Genetic Testing (MeSH) |
| 1 | Genetic Predisposition to Disease (MeSH) |
| 1 | Gait Disorders, Neurologic (therapy) |
| 1 | Gait Disorders, Neurologic (physiopathology) |
| 1 | GAD = generalized anxiety disorder |
| 1 | G2019S |
| 1 | Frontal Lobe (physiology) |
| 1 | Feedback, Physiological (MeSH) |
| 1 | Feasibility Studies (MeSH) |
| 1 | Experimental study |
| 1 | Exercise Therapy (psychology) |
| 1 | Exercise Therapy (MeSH) |
| 1 | Exercise (psychology) |
| 1 | Exercise (physiology) |
| 1 | Evoked Potentials, Motor (physiology) |
| 1 | Ethinyl Estradiol (adverse effects) |
| 1 | Escape Reaction (MeSH) |
| 1 | Epidemiology |
| 1 | Emotions (physiology) |
| 1 | Emotion emotionality |
| 1 | Electrophysiology (MeSH) |
| 1 | Electromyography (MeSH) |
| 1 | Electrocorticography |
| 1 | Educational Status (MeSH) |
| 1 | EPSE = extrapyramidal side-effect |
| 1 | EEG biofeedback |
| 1 | EA1 |
| 1 | Dyskinesias (etiology) |
| 1 | Double-Blind Method (MeSH) |
| 1 | Depression (MeSH) |
| 1 | Deglutition (physiology) |
| 1 | Deep brain stimulation |
| 1 | Deep Brain Stimulation (MeSH) |
| 1 | Data Interpretation, Statistical (MeSH) |
| 1 | Dance |
| 1 | DYT6 |
| 1 | DYT12 |
| 1 | DSMs = Diagnostic and Statistical Manuals |
| 1 | DBT = double-blind trial |
| 1 | Cyclosporine A |
| 1 | Cues (MeSH) |
| 1 | Creativity (MeSH) |
| 1 | Contraceptives, Oral, Combined (adverse effects) |
| 1 | Comprehension (physiology) |
| 1 | Combined Modality Therapy (methods) |
| 1 | Cohort study |
| 1 | Cognition Disorders (psychology) |
| 1 | Cognition Disorders (etiology) |
| 1 | Cognition (physiology) |
| 1 | Cognition (MeSH) |
| 1 | Clinical Trials as Topic (MeSH) |
| 1 | Choreiform disorders |
| 1 | Child (MeSH) |
| 1 | Cerebrovascular Disorders (complications) |
| 1 | Cerebral Cortex (physiopathology) |
| 1 | Cerebellum (physiology) |
| 1 | Case-Control Studies (MeSH) |
| 1 | CCEI = Crown Crisp Experimental Index |
| 1 | CB1 receptor |
| 1 | Brazil (epidemiology) |
| 1 | Brain (anatomy & histology) |
| 1 | Body movement |
| 1 | Biomedical Research (MeSH) |
| 1 | Biofeedback, Psychology (methods) |
| 1 | Behavior |
| 1 | Behavior (physiology) |
| 1 | Basal ganglion |
| 1 | Basal Ganglia (physiopathology) |
| 1 | BNF = British National Formulary |
| 1 | Autogenic Training (methods) |
| 1 | Auditory Perception (physiology) |
| 1 | Arousal (physiology) |
| 1 | Arm (physiopathology) |
| 1 | Antioxidants |
| 1 | Amputation (psychology) |
| 1 | Alpha Rhythm (MeSH) |
| 1 | Adaptation, Physiological (MeSH) |
| 1 | Activities of Daily Living (psychology) |
| 1 | Acoustic Stimulation (MeSH) |
| 1 | ALS |
| 1 | ADHD |
| 1 | ADHD = attention deficit hyperactivity disorder |
| 1 | 5-HT = 5-hydroxytryptamine |
